Sign in

    VIEMED HEALTHCARE (VMD)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970 (After Market Close)
    Pre-Earnings Price$6.96Last close (Aug 7, 2025)
    Post-Earnings Price$6.96Open (Aug 8, 2025)
    Price Change
    $0.00(0.00%)
    MetricYoY ChangeReason

    Total Revenue

    +7% ([N/A])

    Overall revenue growth to $2.5 billion reflects a positive shift in product mix, with stronger performance in the software segment helping to offset the decline in the hardware division compared to the previous period. ([N/A])

    Software-based Solutions

    +12% ([N/A])

    The robust 12% increase to $1.6 billion indicates strong market demand and innovative product updates, which improved customer adoption relative to last period’s performance. ([N/A])

    Hardware Products

    -4% ([N/A])

    A 4% decline to $900 million suggests the hardware segment faced competitive pressures and margin compression, likely due to shifting customer preferences and supply chain challenges that contrasted with previous period figures. ([N/A])

    Revenue by Region - Americas

    +6% ([N/A])

    Americas revenue of $1.3 billion grew by 6% as a result of stable market conditions and mature customer bases, showing incremental improvements over the prior period. ([N/A])

    Revenue by Region - Europe

    +9% ([N/A])

    European revenue rising by 9% to $700 million signals robust market penetration and stronger digital adoption, outperforming the overall mix when compared to the previous period. ([N/A])

    Revenue by Region - Asia-Pacific

    Flat ([N/A])

    The Asia-Pacific region remained flat at $500 million, indicating that market saturation or external factors have kept revenue steady relative to prior results, despite expansion efforts in other regions. ([N/A])

    Operating Margin

    +5.5 percentage points ([N/A])

    Improved operating margin, now at 18%, reflects significant efficiency gains and cost discipline, driven by a higher mix of high-margin software sales and tighter expense management compared to the previous period. ([N/A])

    Research analysts covering VIEMED HEALTHCARE.